Hanmi Pharmaceutical Dividend yield

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
   KRW per share 
 Price  464,000.00
 Dividend  464.00
 Earnings  5,631.07
 Cash-flow  -5,446.01
 Book value  61,866.67
 Equity  59,274.42

Hanmi Pharmaceutical is part of Pharmaceuticals and Biotechnology business, which is part of Health Care industry. Hanmi Pharmaceutical is a company from Korea, and his stocks are publicly traded.

Hanmi Pharmaceutical paid a total dividend of 5,568 million KRW last year, for a market value of 5,568,000 millions (Market Cap 3,253,368 millions). Dividend per share of Hanmi Pharmaceutical is 464.00 KRW, and his stock market price 464,000.00 KRW.

According to the chart below, where dividend yield is displayed, Hanmi Pharmaceutical has a dividend yield of 0.10%, lower than the amount offered by both the market average and companies from Korea. It is also lower than average of Health Care industry. This low dividend yield might has several explanations: company overpriced, expanding their business,...

In addition, you should compare Hanmi Pharmaceutical dividend yield with other Pharmaceuticals and Biotechnology companies or firms from Korea.

Dividend yield of Hanmi Pharmaceutical

Hanmi Pharmaceutical Dividend Payout

About the ability of Hanmi Pharmaceutical to maintain his current dividend of KRW 464.00 per share, an amount that accounts for 0.10%, we should study its payout ratio both on earnings and on cash-flows (see chart below). Hanmi Pharmaceutical payout on ernings is currently 8.24%, which is lower than the market average and companies of Health Care industry, which are 40.41% and 28.58% respectively. Both figures lead us to believe that there is confidence that Hanmi Pharmaceuticalcan maintain his current dividend.

The payout on earnings should be complemented with the payout on cash flow since it is this last amount the one which can be distributed to shareholders. Cash flow per share of Hanmi Pharmaceutical is KRW -5,446.01 per share, which is lower than the dividend per share paid by the company of KRW 464.00, so the company does not generate enough cash to maintain his dividend in the future.

The following figure shows payout ratios over earnings and cashflow of Hanmi Pharmaceutical, compared againt world market average, Korea companies, Health Care industry and Pharmaceuticals and Biotechnology sector companies.

Hanmi Pharmaceutical payout

Hanmi Pharmaceutical Stock performance

Finally, last moth Hanmi Pharmaceutical showed a return of 7.00% compared to a worldwide -5.60% average, and a -7.73% of Health Care firms. Over the last year, the company obtained a -19.00% versus a worldwide performance of a -11.41%. More detailed information can be seen in the following graph for Korea and Pharmaceuticals and Biotechnology firms.

Hanmi Pharmaceutical stock and market return

Next companies

Hanmi Science. Korea. Health Care.

Hannover Rueck SE. Germany. Financials.

Hanon Systems. Korea. Consumer Goods.

Hanssem. Korea. Consumer Goods.

Hanwha. Korea. Industrials.

Hanwha Chemical. Korea. Basic Materials.

Previous companies

Hankyu Hanshin Holdi. Japan. Consumer Services.

Hankook Tire. Korea. Consumer Goods.

Hanjin Shipping. Korea. Industrials.

Hang Seng Bank. Hong-Kong. Financials.

Hang Lung Properties. Hong-Kong. Financials.

Hang Lung Group. Hong-Kong. Financials.



All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.